Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03151811
Title A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN)
Acronym OCEAN
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ROU | POL | NOR | NLD | LTU | ITA | ISR | HUN | GRC | GBR | FRA | EST | ESP | DNK | CZE | BEL | AUT


No variant requirements are available.